Evolus (EOLS) EBITDA Margin Growth (1y) (2020 - 2026)
Evolus (EOLS) EBITDA Margin Growth (1y) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | -1,647.00 |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | -368.00 |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | -17.00 |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | -341.00 |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | -634.00 |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | -538.00 |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 40.00 |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | - |
| 10 | Evolus | 552.49 Mn | 507.32 Mn | 57.18 Mn | 951.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 931.00 |
| Mar 31, 2026 | 1,278.00 |
| Dec 31, 2025 | 760.00 |
| Sep 30, 2025 | 866.00 |
| Jun 30, 2025 | -320.00 |
| Mar 31, 2025 | -710.00 |
| Dec 31, 2024 | 1,122.00 |
| Sep 30, 2024 | 154.00 |
| Jun 30, 2024 | 1,913.00 |
| Mar 31, 2024 | 1,382.00 |
| Dec 31, 2023 | 1,022.00 |
| Sep 30, 2023 | 2,593.00 |
| Jun 30, 2023 | 2,681.00 |
| Mar 31, 2023 | 1,670.00 |
| Dec 31, 2022 | 2,765.00 |
| Sep 30, 2022 | 1,884.00 |
| Jun 30, 2022 | 115.00 |
| Mar 31, 2022 | -11,113.00 |
| Dec 31, 2021 | 47,297.00 |
| Sep 30, 2021 | -2,203.00 |